Name: Dr. Dharmendra Kumar Khatri Assistant Professor dharmendra.niperhyd@nic.in, dkkhatri10@gmail.com +91 40 23074750 Extn- 2014 Google Scholar Citations

ADDRESS, ROOM NO, EMAIL ID

Department of Pharmacology & Toxicology
Room No - 70
NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA

QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

Ph.D. (Tech.): Institute of Chemical Technology, Mumbai (Degree Awarded 2017)
Master of Pharmacy: Institute of Chemical Technology, Mumbai, 9.14 CGPA (AA outstanding Grade)
Bachelor of Pharmacy: Rajasthan University of Health & Sciences

Experience

1. Assistant Professor, Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, March 2021 - Till now
2. Senior Lecturer, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, March 2020 - February 2021
3. Research Scientist, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad, March 2019 - February 2020
4. Assistant Professor, Department of Pharmacology and Toxicology, Dr D.Y. Patil Institute of Pharmaceutical Sciences & Research (DYPIPSR), Pimpri, Pune, August 2017 - February 2019

COURSES HANDLING(PHD/M.PHARM)

PhD: PC 860 - Epigenetics and Diseases
PC 920- Current topics in Cancer Research
MS: PC 611-Pharmacological Screening and Assays
PC-520-General Pharmacology
PC-530-Experimental Pharmacology
PC 620-CNS and Respiratory Pharmacology
PC-630 Autonomic, CVS, Blood Renal & GI Pharmacology
RT-660: Bioethics

PHD STUDENTS/MASTERS STUDENTS

M.S students: Guide-27, Co-Guide: 04, Ongoing (Guide)-06, (Co-Guide)- 04
Ph D students: Guided-03 (Co-Guide),
Ongoing (Guide): 03; Ongoing (Co-Guide): 09

AWARDS / HONOURS

1. Selected for the Lalitha and RavindraNath International Travel Award during Indian Academy of Neuroscience (IAN) 2019 meeting November 18-21, 2019 held at All India Institute of Medical Sciences Ansari Nagar, New Delhi 110029, India.
2. Selected as Indian Ambassador on behalf of International Society of Neurochemistry (ISN) for the year 2019-21.
3. Selected as Next Generation Young Neuroscientist for Basic Science Summer School held at the Osaka University Nakanoshima Center in Osaka, Japan from August 3-4, 2018.
4. Awards for investigators from developing countries in the amount of US$ 750 International Parkinson's Disease Foundation and the Association of Parkinsonism and Related Disorders for poster presentation in XXIII World Congress on Parkinson's Disease and Related Disorders, 19 - 22 August, 2018 in Lyon, France
5. Appreciation award in Research Contribution during 2017-18 at Dr D.Y. Patil Institute of Pharmaceutical Sciences & Research, Pimpri, Pune, India
6. Awards for investigators from developing countries in the amount of US$ 750 by Melvin Yahr International Parkinson's Disease Foundation and the Association of Parkinsonism and Related Disorders for poster presentation in XXII World Congress on Parkinson's Disease and Related Disorders, 12-15 November 2017 at Ho Chi Minh City, Vietnam.
7. Awards for investigators from developing countries in the amount of US$ 1000 by Melvin Yahr International Parkinson's Disease Foundation and the Association of Parkinsonism and Related Disorders for oral presentation in XX World Congress on Parkinson's Disease and Related Disorders, 8-11 December 2013 at Geneva, Switzerland.
8. Travel grant (Partial) from Council of Scientific & Industrial Research, Govt. of India for oral presentation in XX World Congress on Parkinson's Disease and Related Disorders, 8-11 December 2013at Geneva, Switzerland.
9. Travel grant (Partial) from The Centre for International Co-operation in Science (CICS-INSA) for presenting research paper at at 7th Congress of the International Society of Nutrigenetics/ Nutrigenomics (ISNN), October 5-8, 2013,Quebec City, Quebec, Canada.
10. Travel grant from Indian Council of Medical Research (ICMR) for presenting research paper at "3rd World Parkinson Congress (WPC 2013) Palais des congres". Montreal, Quebec, Canada, from 1-5 October, 2013.
11. Secure 1st position in Galaxy Surfactant industry defined problem in Young Innovator Choice Competition (YICC) - 2012 held at Institute of Chemical Technology, Mumbai, India
12. Full Air-fare travel support by Department of Biotechnology (DBT) Government of India, for presenting paper at 13th International Congress of the Society for Ethnopharmacology, Graz, Austria, 2012.

RESEARCH AREAS/INTEREST

The major research area of interest is focused on elucidation of pathogenic mechanism of Parkinson's disease. Specifically, a multidisciplinary approach is employing to investigate the cellular and molecular mechanism underlying pathogenic degeneration of specific neuronal population in the PD brain. Drug screening of novel molecules isolated from plant sources or synthetic congeners for their neuroprotective and neuronal regeneration properties by using animal and cellular models.

1. Neuroscience
2. Neuropharmacology
3. Toxicology

FELLOWSHIPS / GRANTS

Fellowships

1. Junior Research Fellowship by University Grants Commission (UGC)- Government of India for the period of two years during Master’s Degree (2011-2012) at Institute of Chemical Technology, Mumbai, India.
2. Junior Research Fellowship by University Grants Commission (UGC)- Government of India) for the period of Ph.D. degree (2012-2014) at Institute of Chemical Technology, Mumbai, India.
3. Senior Research Fellowship by University Grants Commission (UGC)- Government of India) for the period of Ph.D. degree (from 2015 to 2017 ) at Institute of Chemical Technology, Mumbai, India.




PUBLICATIONS / BOOK CHAPTERS / PATENTS

Book Chapters

1. Dharmendra Kumar Khatri, Jitender Madan, Kiran Jyotic, Shashi Bala Singh. Decoding the signalling cascaded in immunotherapy of cancer: role played by nanoimmunoadjuvants. Multifunctional Nanocarriers (Elsevier, 2021)

Book

1. Dr. Pankaj Kumar Singh, Dharmendra Kumar Khatri, Jitender Madan. An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy. Bentham Sciences, 2022.

Publications

1. Shashi Chandrama Singh, Muskan Choudhary, Atul Mourya , Dharmendra Kumar Khatri , Pankaj Kumar Singh , Jitender Madan , and Harshpal Singh. Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats. The Scientific World Journal. 2022, DOI: https://doi.org/10.1155/2022/6224107
2. Vaskuri G.S. Sainaga Jyothi, Jyoti Pawar, Valencia Fernandes, Rahul Kumar, Chandni Singh, Shashi Bala Singh, Jitender Madan, Dharmendra Kumar Khatri*. Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats. Journal of Drug Delivery Science and Technology. 2022, 70:103195 (IF:3.981)DOI: https://doi.org/10.1016/j.jddst.2022.103195.
3. Balram Prajapati, Indrani Maji, Rahul Kumar, Devendrasigh Tomar, Dharmendra K. Khatri, Jitender Madan, Pankaj Kumar Singh. Strategy to Counteract the Pyrazinamide Induced Hepatotoxicity by Developing Naringin Based Co-amorphous System with Supplementary Benefits. Journal of Drug Delivery Science and Technology. 2022, 69, 103181 (IF:3.981) DOI: 10.1016/j.jddst.2022.103181.
4. Bhoomika Sherkhane, Anil Kumar Kalvala, Vijay Kumar Arruri, Dharmendra Khatri*, Shashi Bala Singh*. Renoprotective Potential of Myo-inositol on Diabetic kidney disease: Focus on Role of PINK1/Parkin Pathway and Mitophagy Receptors. Journal of Biochemical and Molecular Toxicology. 2022. (IF:3.652). DOI:https://doi.org/10.1002/jbt.23032
5. Vaskuri GS Sainaga Jyothi, Shaik Mahammad Ghouse, Dharmendra Kumar Khatri, Srinivas Nanduri, Shashi Bala Singh, Jitender Madan. Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration? Journal of Drug Delivery Science and Technology. 2022, 70: 103176 (IF:3.981) DOI: https://doi.org/10.1016/j.jddst.2022.103176
6. Gundu C, Arruri VK, Sherkhane B, Khatri DK*, Singh SB. GSK2606414 attenuates PERK/p-eIF2α/ATF4/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells. Current Research in Pharmacology and Drug Discovery. 2022; 3:100087. DOI: https://doi.org/10.1016/j.crphar.2022.100087
7. Chayanika Gundu, Vijay Kumar Arruri, Bhoomika Sherkhane, Dharmendra Kumar Khatri* Shashi Bala Singh. Indole-3-propionic acid attenuates high glucose induced ER stress response andaugments mitochondrial function by modulating PERK-IRE1-ATF4-CHOP signalling in experimental diabetic neuropathy. Archives of Physiology and Biochemistry. 2022 (4.076) DOI: 10.1080/13813455.2021.2024577
8. Shashi Chandrama Singh, Dharmendra Kumar Khatri, Kulbhaskar Singh, Vinay Kumar Kanchupalli, Jitender Madan, Shashi Bala Singh b, Harshpal Singh “Molecular encapsulation of andrographolide in 2-hydroxypropyl-β-cyclodextrin cavity: synthesis, characterization, pharmacokinetic and in vitro antiviral activity analysis against SARS-CoV-2”. Heliyon. 7 (2021) e07741. https://doi.org/10.1016/j.heliyon.2021.e07741.
9. Indrani Maji, Srushti Mahajan, Anitha Sriram, Ravindra Vasave, Pravin Medtiya, Rahul Kumar, Dharmendra K. Khatri, Jitendra Madan, Dr. Shashi Bala Singh, Pankaj Kumar Singh. Review article on “Solid Self Emulsifying Drug Delivery System: Superior Mode for Oral Delivery of Hydrophobic Cargos”. Journal of Controlled Release. September 2021: 337, 646-660 (IF:9.776) 10.1016/j.jconrel.2021.08.013.
10. Ambekar T, Pawar J, Rathod R, Patel M, Fernandes V, Kumar R, Singh SB, Khatri D. Mitochondrial Quality Control: Epigenetic Signatures and Therapeutic Strategies. Neurochemistry International. 2021 Jun 8: 148: 105095. (IF: 3.92) 10.1016/j.neuint.2021.105095
11. Bhoomika Sherkhane, Gundu Chayanika, Anika Sood, Dharmendra Kumar Khatri, Shashi Bala Singh. Mitochondrial remodelling: a vicious cycle in diabetic complications. Molecular Biology Reports. 2021 (IF: 2.4) DOI :10.1007/s11033-021-06408-8.
12. Khan I, Preeti K, Fernandes V, Khatri DK, Singh SB. Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders. Cellular and Molecular Neurobiology. 2021 May 1:1-21. (IF: 2.01) https://doi.org/10.1007/s10571-021-01093-4
13. Kadbhane A, Patel M, Srivastava S, Singh PK, Madan J, Singh SB, Khatri DK. Perspective Insights and Application of Exosomes as a Novel Tool against Neurodegenerative Disorders: An Expository Appraisal. Journal of Drug Delivery Science and Technology. 2021 Apr 16:102526. (IF:2.8) https://doi.org/10.1016/j.jddst.2021.102526
14. Khatri DK, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S, Singh SB. Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Current Research in Pharmacology and Drug Discovery. 2021 Jan 1;2:100022. https://doi.org/10.1016/j.crphar.2021.100022
15. Nellaiappan K, Kumari P, Khatri DK, Singh SB. Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies. Current Diabetes Reviews. 2021 Mar 8. (IF: 2.5) DOI: 10.2174/1573399817666210309104203
16. Arruri VK, Gundu C, Khan I, Khatri DK, Singh SB. PARP overactivation in neurological disorders. Molecular Biology Reports. 2021 Mar 25:1-9. (IF: 2.1) https://doi.org/10.1007/s11033-021-06285-1
17. Sheela Modani, Devendra Tomar, Suma Tangirala, Anitha Sriram, Neelesh Mehra, Rahul Kumar, Dharmendra Khatri, Pankaj Kumar Singh. An updated review on exosomes: Biosynthesis to clinical applications. Journal of Drug Targeting. 1-6, 2021 (IF: 3.38). https://doi.org/10.1080/1061186X.2021.1894436
18. Arruri VK, Gundu C, Kalvala AK, Sherkhane B, Khatri DK, Singh SB. Carvacrol abates NLRP3 inflammasome activation by augmenting Keap1/Nrf-2/p62 directed autophagy and mitochondrial quality control in neuropathic pain. Nutritional Neuroscience. 2021 Mar 2:1-6. (IF:4.02) https://doi.org/10.1080/1028415X.2021.1892985
19. Sharma N, Modak C, Singh PK, Kumar R, Khatri D, Singh SB. Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2?. International journal of biological macromolecules. 2021 Feb 16. (IF:516). https://doi.org/10.1016/j.ijbiomac.2021.02.090
20. Devendrasingh Tomar , Pankaj K. Singh , Sajidul Hoque , Sheela Modani , Anitha Sriram , Rahul Kumar , Jitender Madan , Dharmendra Khatri & Kamal Dua, “Amorphous systems for delivery of nutraceuticals: challenges opportunities” in Critical Reviews in Food Science and Nutrition. 2020, 1-18. (IF: 7.86) https://doi.org/10.1080/10408398.2020.1836607.
21. Dharmendra Kumar Khatri, Mamta Choudhary, Anika Sood, Shashi Bala Singh. “Anxiety: An ignored aspect of Parkinson’s disease lacking attention” in Biomedicine & Pharmacotherapy 131 (2020) 110776. (IF: 4.54) https://doi.org/10.1016/j.biopha.2020.110776
22. Dharmendra Kumar Khatri, Archana Ramesh Juvekar “Abrogation of Locomotor Impairment In A Rotenone-Induced Drosophila melanogaster and Zebrafish Model of Parkinson’s Disease by Ellagic Acid and Curcumin” International Journal of Nutrition, Pharmacology, Neurological Diseases, 2016: 6(2);90-96.
23. Dharmendra Kumar Khatri, Archana Ramesh Juvekar “Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid” Pharmacognosy Magazine, 2016: 12 (2): S116–S120.
24. DK Khatri, AR Juvekar “Propensity of Hyoscyamus niger seeds methanolic extract to allay stereotaxically rotenone-induced Parkinson’s disease symptoms in rats” in Oriental Pharmacy and Experimental Medicine. 2015:15(4); 327-339.
25. Sabir Husain Attar, Dharmendra Kumar Khatri, Dnyaneshwar Nagmoti, Archana Juvekar “SAFETY ASSESSMENT OF L-DOPA AND HYOSCINE HYDROBROMIDE IN COMBINATION: ACUTE AND SUB-ACUTE ORAL TOXICITY STUDIES” International Journal of Pharmacy and Pharmaceutical Sciences. 2015:7(7); 226-230.
26. Sabir Husain Attar, Dharmendra Kumar Khatri, Archana Juvekar* “EVALUATION OF REPEATED DOSE-90-DAY ORAL TOXICITY STUDY OF L-DOPA AND HYOSCINE HYDRBROMIDE COMBINATION IN RATS” International Journal of Pharmacy and Pharmaceutical Sciences. 2015:7(11); 241-245.
27. Dharmendra Kumar Khatri1, Manjula Konka, Archana R Juvekar, Evaluation of Anti-Inflammatory Activity of Mimusops Elengi Extracts In Different In-Vitro and In-Vivo Models, International Journal of Pharma and Bio Sciences 2014: 5(1); 259 – 268.
28. DHARMENDRA K KHATRI, Parikshit Juvekar, Archana Ramesh Juvekar, “Phytochemical Investigation and In-vitro Antioxidant Activities of the Aqueous and Methanolic Extracts of “Indigofera Cordifolia” seeds” International Journal of Pharmacy and Pharmaceutical Sciences. 2013:5(2); 71-7.
29. Dnyaneshwar M. Nagmoti, DHARMENDRA K. KHATRI, Parikshit R. Juvekar, Archana R. Juvekar., “Antioxidant activity and free radical-scavenging potential of Pithecellobium dulce Benth seed extracts” Free Radicals and Antioxidants. 2012:2(2); 37-43.
30. KHATRI, D. K.; Patidar, V.; Shah, S.; Kumar, R.; Singh, P. K.; Singh, S. B.; Khatri, D. K. A Molecular Insight of Inflammatory Cascades in Rheumatoid Arthritis and Anti-Arthritic Potential of Phytoconstituents. Mol. Biol. Rep. 2021. https://doi.org/10.1007/s11033-021-06986-7.
31. KHATRI, D. K.; Sood, A.; Preeti, K.; Fernandes, V.; Khatri, D. K.; Singh, S. B. Glia: A Major Player in Glutamate GABA Dysregulation‐mediated Neurodegeneration. J. Neurosci. Res. 2021. https://doi.org/10.1002/jnr.24977.
32. Dondulkar, A.; Akojwar, N.; Katta, C.; Khatri, D. K.; Mehra, N. K.; Singh, S. B.; Madan, J. Inhalable Polymeric Micro and Nano-Immunoadjuvants for Developing Therapeutic Vaccines in the Treatment of Non-Small Cell Lung Cancer. 2021, 27. https://doi.org/10.2174/1381612827666211104155604.
33. Famta, P.; Shah, S.; Khatri, D. K.; Guru, S. K.; Singh, S. B.; Srivastava, S. Enigmatic Role of Exosomes in Breast Cancer Progression and Therapy. Life Sci. 2021, 120210. https://doi.org/10.1016/j.lfs.2021.120210.
34. Sriram, A.; Tangirala, S.; Atmakuri, S.; Hoque, S.; Modani, S.; Srivastava, S.; Mahajan, S.; Maji, I.; Kumar, R.; Khatri, D. Budding Multi-Matrix Technology—a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 2021, 22 (8), 1–40.
35. Gugulothu, D.; Choudhary, S. K.; Khatri, D. K. The Extraction and Investigation of Polysaccharide Mucilages for Use as Excipients in Drug Delivery Systems and Their Application for Developing Floating Tablets of Silymarin. J. Excipients Food Chem. 2021, 12 (4), 70–86.
36. Iyer, A.; Jyothi, V. G. S. S.; Agrawal, A.; Khatri, D. K.; Srivastava, S.; Singh, S. B.; Madan, J. Does Skin Permeation Kinetics Influence Efficacy of Topical Dermal Drug Delivery System?: Assessment, Prediction, Utilization, and Integration of Chitosan Biomacromolecule for Augmenting Topical Dermal Drug Delivery in Skin. J. Adv. Pharm. Technol. Res. 2021, 12 (4), 345.

Patents

S.No	Name of the Inventor	Title of Invention	Application No
1	Rahul Kumar, Nandkumar Doijad, Dharmendra K Khatri, Shashi Bala Singh, Keshav Dev	Inhalable composition of chlorine for treatment of respiratory viral infection	IN202141029410
2	Aniket Mandhare, Nusrat Begum, Dharmendra Kumar Khatri, Jitender Madan, Shashi Bala Singh	Cycloencapsulated andrographolide, preparation methodand application thereof	IN202041052820
3	Katta Chanti, Sheoshree Bhattacharjee, Pankaj Kumar Singh, Dharmendra Kumar Khatri, Jitender Madan, Shashi Bala Singh, Keshav Deo	Antiwrinkle topical composition of sodium alpha-ketoglutarate and methods thereof	IN202041051170
4	Anitha Sriram, Pankaj Kumar Singh, Dr. Shashi Bala Singh, Sajidul Hoque, Dr. Rahul Kumar, Dr. Dharmendra Khatri	Osimeritinib Mesylate Plga Nanoparticles with Ligands In Lung Cancer Therapy	IN202041051951
5	Pankaj Kumar Singh, Yojana Bhor, Rahul Kumar, Dharmendra K Khatri, Shashi Bala Singh, Keshav Dev	Novel composition of copper alpha-ketoglutarate and methods thereof	IN202041047663
6	Vaskuri G S Sainaga Jyothi, Jitender Madan, Rahul Kumar, Jyoti Pawar, Dharmendra Kumar Khatri, Shashi Bala Singh	Film forming topical dermal spray of meloxicam for the management of pain and inflammation	IN202041007562
7	Khatri D. K., Chitlange S. S.	Aqua-actophotometer for the evaluation of locomotor behavior of aquatic animals	IN201821014852





INVITED TALKS

1. Delivered talk in a Symposium “Nutrition, Brain Aging, and Neurodegeneration” during FIPS INTERNATIONAL e-CONFERENCE IX Annual Symposium of Federation of Indian Physiological Societies (FIPS) 2022 organized by NIPER Hyderabad, India during March 25 – 27, 2022.
2. Delivered talk in a Symposium “NeuroGlia in Health and Disease” during IAN INTERNATIONAL E-CONFERENCE XXXIX Annual Meeting of Indian Academy of Neurosciences December 16 –19, 2021, Kolkata, India
3. Delivered talk in a Symposium “Nature and its Impact on Aging and Mental Health” during IAN INTERNATIONAL E-CONFERENCE XXXVIII Annual Meeting of Indian Academy of Neurosciences Basic and Clinical Neurosciences: Bridging the Gaps October 4 – 7, 2020, Hyderabad, Telangana, India
4. Delivered talk in a Webinar “Pre-clinical and Molecular Methods in Neuroscience” on “Insights in Neurobehavioral Rodent Studies” August 13th & 14th, 2020 at National Institute of Pharmaceutical Education & Research-Hyderabad, India.
5. Delivered talk in a Symposium “Neurodevelopmental and Neurodegenerative Disorders” during XXVII Annual Meeting of Indian Academy of Neurosciences, November 18-21, 2019, held All India Institute of Medical Sciences Ansari Nagar, New Delhi 110029, India.
6. Delivered lecture on “Rational Approaches in Designing Animal Study” at NIPER-DRILS Industry Oriented Training Program, 16-20 December, held at National Institute of Pharmaceutical Education & Research-Hyderabad, India.



SPONSORED PROJECTS

S.No	Title of the Project	Funding Organization	Role	Amount	Status
1	To perform the stereotaxic surgery using rotenone to create mice model of Parkinson’s Disease	Sai Life Sciences, Hyderabad, India	Principal Investigator	Rs. 1,77,000.00	Ongoing
2	Development of Novel Eye Drops of fixed dose combination for Effective Ocular Delivery	DST, Govt of India.	Co-Investigator (Co-PI)	Rs. 29,90,000.00	Ongoing
3	Extraction, Charaterization and Pre-clinical Pharmacodynamics Assesmant of Promising Unani-Medicines against Hepatic Disease	Central Council of Research in Unani Medicine (CCRUM), Govt of India.	Co-Investigator (Co-PI)	Rs. 24,53,000.00	Ongoing
4	To study the efficacy of therapeutic plant molecule in animal models to treat Chronic Obstructive Pulmonary Disease (COPD) by the lung regeneration/repair process	NBI Biosciences Pvt. Ltd, Gurgaon, India.	Principal Investigator (PI)	Rs. 16,67,930.00	Ongoing
5	Development and evaluation of oral drug delivery systems for colon targeting of drugs for the local & systemic actions	NBI Biosciences Pvt. Ltd, Gurgaon, India.	Co-Investigator (Co-PI)	Rs. 8,26,000.00	Ongoing
6	Design, synthesis and biological evaluation of new GSK3 beta inhibitors as promising therapeutic agents for treating Traumatic brain injury and consequent neuronal degenerative diseases	Indian Council of Medical Research (ICMR), Govt. of India.	Co-Investigator (Co-PI)	Rs. 50,00,000.00	Ongoing
7	In vitro screening of Dopamine decarboxylase (DDC) inhibition potential and Blood brain barrier (BBB) status of plant-based molecules	NBI Biosciences Pvt. Ltd	Principal Investigator (PI)	Rs. 6,17,249.00	Ongoing
8	Inhalation Toxicity Study of “a aqueous chlorine inhalation LifeViroTreat formulation through nebulizer for the treatment of covidd-19 and other viral infections”	Lifeactivus Private Limited, Vila No. 110, Prestige Park, Kompally. Medchal-500100 Hyderabad	Principal Investigator (PI)	Rs. 5,64,900.00	Ongoing
9	Development of andrographolide-cyclodexrtin inclusion complex and evaluation of its oral bioavailability, acute and sub-acute toxicity in experimental animals	M/s Ambe Phytoextracts Private Limited Delhi-110092. (Private)	Co-Investigator (Co-PI)	Rs. 27,50,452.56	Ongoing
10	Acute oral, repeated does toxicity and anti-tumor study of Bleomycin sulphate nanoformulation	M/S Oniosomes HealthCare Private Limited Mohali-Punjab. (Private)	Principal Investigator (PI)	Rs. 5,01,500	Ongoing
11	Category 1B: Research Supplies for use in the applicant’s home laboratory) to the Committee for Aid and Education in Neurochemistry	International Society for Neurochemistry (ISN), Geneva, Switzerland.	Principal Investigator (PI)	4000 US$	Ongoing
12	Safety Profile of Different Marketed Bhasma Preparations	AYUSH-CoE Student Fellowship Program scheme Exploring AYUSH-CoE Center for Complementary and Integrative Health (CCIH) Savitribai Phule Pune University, Maharashtra, India. (Govt.)	Principal Investigator (PI)	Rs. 27,000.00	Completed
13	Toxicity Study of OIClean 01 Herbal Blend	Interceptive Med-Science Laboratories Private Limited, Bangalore, India. (Private)	Principal Investigator (PI)	Rs. 3,00,000.00	Completed





Laboratory facilities developed for research / teaching:

1. Established Stereotaxic Surgery Model
2. Setup complete neurobehavioral facility



ADDITIONAL RESPONSIBILITIES

1. Member Institute Animal Ethics Committee
2. Sports In-charge
3. Member of Internal Audit committee




ANY OTHER INFORMATION

1. Member of The European Behavioural Pharmacology Society (EBPS).
2. Member of Society for Neuroscience (SFN)
3. Member of The Federation of European Neuroscience Societies (FENS).
4. Member of The International Society for Neurochemistry (ISN).
5. Member of International Parkinson and Movement Disorder Society (MDS).
6. Life Time Member of Indian Academy of Neuroscience (IAN)
7. Member of International Society for Pediatric and Adolescent Diabetes (ISPAD)
8. Member of the UDCT Alumni Association (UAA), Institute of Chemical Technology, Mumbai.